SCHEMBL8563763

SCHEMBL8563763

Clc1ccc2c(c1)CNc1ccccc1O2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.67
GAA P10253 2/20 0.67
MAPT P10636 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
KDM4E B2RXH2 2/20 0.41
HTT P42858 1/20 0.41
AHR P35869 2/20 0.41
ALOX5 P09917 1/20 0.41
EGFR P00533 2/20 0.40
DRD2 P14416 6/20 0.38
DRD4 P21917 6/20 0.38
CHRM2 P08172 3/20 0.38
HTR1A P08908 3/20 0.38
ADRA2A P08913 3/20 0.38
ADRA2B P18089 3/20 0.38
ADRA2C P18825 3/20 0.38
DRD1 P21728 3/20 0.38
SLC6A2 P23975 3/20 0.38
HTR2A P28223 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9273786 0.88 GAA (0.49) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL6970933 0.87 NPSR1 (0.67) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL7885518 0.87 GAA (0.67) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL8556344 0.84 NPSR1 (0.67) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL1368071 0.81 GAA (1.00) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL8557450 0.81 GAA (0.67) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL8560344 0.81 GAA (0.67) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL4800611 0.79 GAA (0.44) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL8559100 0.78 GAA (0.54) NPSR1GAAMAPTMEN1KMT2A
SCHEMBL9399943 0.75 EGFR (0.52) NPSR1GAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640592-B1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID CO (US) 1998-12-30 EP disclosed
US-5461046-A Analgesics G. D. SEARLE & CO. (US) 1995-10-24 US disclosed
EP-0640592-A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1995-03-01 EP disclosed
US-5393747-A Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists G. D. SEARLE & CO. (US) 1995-02-28 US disclosed
US-5304644-A 1-,2-,3-,4-,5-,6-,7-,8- and/or 9 substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain G. D. SEARLE & CO. (US) 1994-04-19 US disclosed
EP-0583408-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1994-02-23 EP disclosed
US-5283240-A Administering prostaglandin antagonists G. D. SEARLE & CO. (US) 1994-02-01 US disclosed
US-5189033-A Analgesics, antiiflammatory agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-23 US disclosed
US-5182272-A 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain G. D. SEARLE & CO. (US) 1993-01-26 US disclosed
WO-1992019605-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G. D. SEARLE & CO. (US) 1992-11-12 WO disclosed
EP-0512399-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 EP disclosed
EP-0480641-A1 Tricyclic heterocycles ZENECA LIMITED (GB) 1992-04-15 EP disclosed